Improving Familial Hypercholesterolemia Index Case Detection: Sequential Active Screening from Centralized Analytical Data
Open Access
- 13 February 2021
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (4) , 749
Abstract
The majority of familial hypercholesterolemia index cases (FH-IC) remain underdiagnosed and undertreated because there are no well-defined strategies for the universal detection of FH. The aim of this study was to evaluate the diagnostic yield of an active screening for FH-IC based on centralized analytical data. From 2016 to 2019, a clinical screening of FH was performed on 469 subjects with severe hypercholesterolemia (low-density lipoprotein cholesterol ≥220 mg/dL), applying the Dutch Lipid Clinic Network (DLCN) criteria. All patients with a DLCN ≥ 6 were genetically tested, as were 10 patients with a DLCN of 3–5 points to compare the diagnostic yield between the two groups. FH was genetically confirmed in 57 of the 84 patients with DLCN ≥ 6, with a genetic diagnosis rate of 67.9% and an overall prevalence of 12.2% (95% confidence interval: 9.3% to 15.5%). Before inclusion in the study, only 36.8% (n = 21) of the patients with the FH mutation had been clinically diagnosed with FH; after genetic screening, FH detection increased 2.3-fold (p < 0.001). The sequential, active screening strategy for FH-IC increases the diagnostic yield for FH with a rational use of the available resources, which may facilitate the implementation of FH universal and family-based cascade screening strategies.Keywords
Funding Information
- Sanofi España (-)
- Amgen España (-)
- Chair of Advanced Therapies in Cardiovascular Pathologies, University of Málaga (-)
This publication has 41 references indexed in Scilit:
- Systematic Detection of Familial Hypercholesterolaemia in Primary Health Care: A Community Based Prospective Study of Three MethodsHeart, Lung and Circulation, 2015
- Diagnóstico y tratamiento de la hipercolesterolemia familiar en España: documento de consensoAtencion Primaria, 2015
- Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis SocietyEuropean Heart Journal, 2013
- Molecular characterization of familial hypercholesterolemia in SpainAtherosclerosis, 2012
- Mutation detection rate and spectrum in familial hypercholesterolaemia patients in the UK pilot cascade projectClinical Genetics, 2010
- Efficacy of statins in familial hypercholesterolaemia: a long term cohort studyBMJ, 2008
- Comparison of Genetic Versus Clinical Diagnosis in Familial HypercholesterolemiaThe American Journal of Cardiology, 2008
- Child-parent screening for familial hypercholesterolaemia: screening strategy based on a meta-analysisBMJ, 2007
- Genetic screening protocol for familial hypercholesterolemia which includes splicing defects gives an improved mutation detection rateAtherosclerosis, 2005
- The relationship of molecular genetic to clinical diagnosis of familial hypercholesterolemia in a Danish populationAtherosclerosis, 2005